264 related articles for article (PubMed ID: 29904936)
1. TPX2 gene silencing inhibits cell proliferation and promotes apoptosis through negative regulation of AKT signaling pathway in ovarian cancer.
Tian Y; Liu LL; Guo DM; Wang Y; Zha WH; Li Y; Wu FJ
J Cell Biochem; 2018 Sep; 119(9):7540-7555. PubMed ID: 29904936
[TBL] [Abstract][Full Text] [Related]
2. Targeting TPX2 suppresses proliferation and promotes apoptosis via repression of the PI3k/AKT/P21 signaling pathway and activation of p53 pathway in breast cancer.
Chen M; Zhang H; Zhang G; Zhong A; Ma Q; Kai J; Tong Y; Xie S; Wang Y; Zheng H; Guo L; Lu R
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):74-82. PubMed ID: 30454896
[TBL] [Abstract][Full Text] [Related]
3. TPX2 promotes cell proliferation and migration via PLK1 in OC.
Ma S; Rong X; Gao F; Yang Y; Wei L
Cancer Biomark; 2018; 22(3):443-451. PubMed ID: 29865033
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of microRNA-335-5p reduces inflammation via negative regulation of the TPX2-mediated AKT/GSK3β signaling pathway in a chronic rhinosinusitis mouse model.
Gu X; Yao X; Liu D
Cell Signal; 2020 Jun; 70():109596. PubMed ID: 32156642
[TBL] [Abstract][Full Text] [Related]
5. MiR-29a-5p inhibits proliferation and invasion and induces apoptosis in endometrial carcinoma via targeting TPX2.
Jiang T; Sui D; You D; Yao S; Zhang L; Wang Y; Zhao J; Zhang Y
Cell Cycle; 2018; 17(10):1268-1278. PubMed ID: 29888640
[TBL] [Abstract][Full Text] [Related]
6. TPX2 promotes ovarian tumorigenesis by interacting with Lamin A/C and affecting its stability.
Meng X; Cao J; Zheng H; Ma X; Wang Y; Tong Y; Xie S; Lu R; Guo L
Cancer Med; 2023 Apr; 12(8):9738-9748. PubMed ID: 36789877
[TBL] [Abstract][Full Text] [Related]
7. FAM83D inhibits autophagy and promotes proliferation and invasion of ovarian cancer cells via PI3K/AKT/mTOR pathway.
Zhu H; Diao S; Lim V; Hu L; Hu J
Acta Biochim Biophys Sin (Shanghai); 2019 May; 51(5):509-516. PubMed ID: 30939187
[TBL] [Abstract][Full Text] [Related]
8. CNOT7 modulates biological functions of ovarian cancer cells via AKT signaling pathway.
Yu J; Hu X; Chen X; Zhou Q; Jiang Q; Shi Z; Zhu H
Life Sci; 2021 Mar; 268():118996. PubMed ID: 33412213
[TBL] [Abstract][Full Text] [Related]
9. REG3A promotes proliferation and DDP resistance of ovarian cancer cells by activating the PI3K/Akt signaling pathway.
Jiang L; Liu Y; Liu M; Zheng Y; Chen L; Shan F; Ji J; Cao Y; Kai H; Kang X
Environ Toxicol; 2024 Jan; 39(1):85-96. PubMed ID: 37665173
[TBL] [Abstract][Full Text] [Related]
10. The critical role of dysregulated Hh-FOXM1-TPX2 signaling in human hepatocellular carcinoma cell proliferation.
Wang Y; Wang H; Yan Z; Li G; Hu G; Zhang H; Huang D; Wang Y; Zhang X; Yan Y; Lu Q; Cheng M; Luo S
Cell Commun Signal; 2020 Jul; 18(1):116. PubMed ID: 32723329
[TBL] [Abstract][Full Text] [Related]
11. TPX2 Level Correlates with Hepatocellular Carcinoma Cell Proliferation, Apoptosis, and EMT.
Liang B; Jia C; Huang Y; He H; Li J; Liao H; Liu X; Liu X; Bai X; Yang D
Dig Dis Sci; 2015 Aug; 60(8):2360-72. PubMed ID: 26025609
[TBL] [Abstract][Full Text] [Related]
12. RHPN1‑AS1 promotes ovarian carcinogenesis by sponging miR‑485‑5p and releasing TPX2 mRNA.
Cui S; Li C
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33907841
[TBL] [Abstract][Full Text] [Related]
13. TPX2 silencing exerts anti‑tumor effects on hepatocellular carcinoma by regulating the PI3K/AKT signaling pathway.
Huang DH; Jian J; Li S; Zhang Y; Liu LZ
Int J Mol Med; 2019 Dec; 44(6):2113-2122. PubMed ID: 31638175
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of targeting protein for Xklp2 silencing for pancreatic cancer.
Miwa T; Kokuryo T; Yokoyama Y; Yamaguchi J; Nagino M
Cancer Med; 2015 Jul; 4(7):1091-100. PubMed ID: 25914189
[TBL] [Abstract][Full Text] [Related]
15. Targeting of TRX2 by miR-330-3p in melanoma inhibits proliferation.
Yao Y; Zuo J; Wei Y
Biomed Pharmacother; 2018 Nov; 107():1020-1029. PubMed ID: 30257313
[TBL] [Abstract][Full Text] [Related]
16. Exosomes transferring long non-coding RNA FAL1 to regulate ovarian cancer metastasis through the PTEN/AKT signaling pathway.
Zhang Q; Len TY; Zhang SX; Zhao QH; Yang LH
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):43-54. PubMed ID: 31957817
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-506-3p inhibits proliferation and promotes apoptosis in ovarian cancer cell via targeting SIRT1/AKT/FOXO3a signaling pathway.
Xia XY; Yu YJ; Ye F; Peng GY; Li YJ; Zhou XM
Neoplasma; 2020 Mar; 67(2):344-353. PubMed ID: 31973537
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor.
Liu X; Li G
Int J Clin Exp Pathol; 2015; 8(9):10605-14. PubMed ID: 26617770
[TBL] [Abstract][Full Text] [Related]
19. TPX2 siRNA regulates growth and invasion of esophageal cancer cells.
Liu HC; Zhang GH; Liu YH; Wang P; Ma JF; Su LS; Li SL; Zhang L; Liu JW
Biomed Pharmacother; 2014 Sep; 68(7):833-9. PubMed ID: 25239289
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
